Patient demographics
| Clinical/demographic characteristics . | Patients without CMBs (N = 28) . | Patients with CMBs (N = 21) . | ||||||
|---|---|---|---|---|---|---|---|---|
| Female, no. of patients (%) | 15 (54) | 14 (67) | ||||||
| Age at time of MRI (y), mean (range) | 42 (20-84) | 40 (18-69) | ||||||
| Age at time of diagnosis (y), mean (range) | 37 (15-83) | 29 (3-63) | ||||||
| Disease duration (mo), mean (range) | 63 (1-232) | 124 (4-486) | ||||||
| Platelet count day of MRI, mean (range) | 109 (11-393) | 73 (4-327) | ||||||
| Lowest platelet count, mean (range) | 8 (0-25) | 4 (1-13) | ||||||
| Number of prior treatments, mean (range) | 4 (1-8) | 6 (1-17) | ||||||
| Bleeding score | 0-1 | 2 | 3 | 4-5 | 0-1 | 2 | 3 | 4-5 |
| Skin, no. of patients | 6 | 7 | 11 | 0 | 6 | 4 | 7 | 0 |
| Visible mucosae, no. of patients | 14 | 8 | 2 | 0 | 8 | 5 | 4 | 0 |
| Organs, no. of patients | 15 | 6 | 3 | 0 | 10 | 1 | 5 | 1 |
| Diabetes, no. of patients | 0 | 0 | ||||||
| Hypertension, no. of patients | 1 | 1 | ||||||
| Heart disease, no. of patients | 1 | 2 | ||||||
| Antiplatelet/anticoagulant agents, no. of patients | 2 | 2 | ||||||
| Clinical/demographic characteristics . | Patients without CMBs (N = 28) . | Patients with CMBs (N = 21) . | ||||||
|---|---|---|---|---|---|---|---|---|
| Female, no. of patients (%) | 15 (54) | 14 (67) | ||||||
| Age at time of MRI (y), mean (range) | 42 (20-84) | 40 (18-69) | ||||||
| Age at time of diagnosis (y), mean (range) | 37 (15-83) | 29 (3-63) | ||||||
| Disease duration (mo), mean (range) | 63 (1-232) | 124 (4-486) | ||||||
| Platelet count day of MRI, mean (range) | 109 (11-393) | 73 (4-327) | ||||||
| Lowest platelet count, mean (range) | 8 (0-25) | 4 (1-13) | ||||||
| Number of prior treatments, mean (range) | 4 (1-8) | 6 (1-17) | ||||||
| Bleeding score | 0-1 | 2 | 3 | 4-5 | 0-1 | 2 | 3 | 4-5 |
| Skin, no. of patients | 6 | 7 | 11 | 0 | 6 | 4 | 7 | 0 |
| Visible mucosae, no. of patients | 14 | 8 | 2 | 0 | 8 | 5 | 4 | 0 |
| Organs, no. of patients | 15 | 6 | 3 | 0 | 10 | 1 | 5 | 1 |
| Diabetes, no. of patients | 0 | 0 | ||||||
| Hypertension, no. of patients | 1 | 1 | ||||||
| Heart disease, no. of patients | 1 | 2 | ||||||
| Antiplatelet/anticoagulant agents, no. of patients | 2 | 2 | ||||||